Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shenzhen SiBiono GeneTech Co. Ltd.
DescriptionRecombinant adenoviral human p53 gene combined with radio and chemotherapy
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase II
Standard IndicationHead and neck cancer
Indication DetailsTreat advanced head and neck cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today